Go Pro

Owlet (OWLT) Competitors

Owlet logo
$5.27 +0.13 (+2.53%)
As of 10:27 AM Eastern
This is a fair market value price provided by Massive. Learn more.

OWLT vs. CTKB, PRE, LAB, OPTX, and MASS

Should you buy Owlet stock or one of its competitors? MarketBeat compares Owlet with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Owlet include Cytek Biosciences (CTKB), Prenetics Global (PRE), Standard BioTools (LAB), Syntec Optics (OPTX), and 908 Devices (MASS).

How does Owlet compare to Cytek Biosciences?

Owlet (NYSE:OWLT) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Owlet has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market. Comparatively, Cytek Biosciences has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market.

Owlet has higher earnings, but lower revenue than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$107.06M1.43-$39.68M-$3.07N/A
Cytek Biosciences$201.49M2.71-$66.54M-$0.57N/A

Cytek Biosciences has a net margin of -36.25% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Cytek Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Cytek Biosciences -36.25%-10.07%-7.56%

72.6% of Owlet shares are owned by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are owned by institutional investors. 36.2% of Owlet shares are owned by insiders. Comparatively, 10.4% of Cytek Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Owlet presently has a consensus price target of $15.00, indicating a potential upside of 184.63%. Cytek Biosciences has a consensus price target of $5.69, indicating a potential upside of 34.62%. Given Owlet's stronger consensus rating and higher probable upside, research analysts plainly believe Owlet is more favorable than Cytek Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, Owlet and Owlet both had 2 articles in the media. Owlet's average media sentiment score of 1.34 beat Cytek Biosciences' score of 0.11 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cytek Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Owlet beats Cytek Biosciences on 9 of the 14 factors compared between the two stocks.

How does Owlet compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and Owlet (NYSE:OWLT) are related small-cap companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

In the previous week, Owlet had 1 more articles in the media than Prenetics Global. MarketBeat recorded 2 mentions for Owlet and 1 mentions for Prenetics Global. Owlet's average media sentiment score of 1.34 beat Prenetics Global's score of 0.00 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prenetics Global
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Prenetics Global has higher earnings, but lower revenue than Owlet. Prenetics Global is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39M3.42-$37.71M-$4.58N/A
Owlet$107.06M1.43-$39.68M-$3.07N/A

Prenetics Global has a beta of 0.26, meaning that its stock price is 74% less volatile than the broader market. Comparatively, Owlet has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market.

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Owlet has a net margin of -42.54% compared to Prenetics Global's net margin of -62.45%. Owlet's return on equity of 0.00% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-62.45% -20.33% -15.42%
Owlet -42.54%N/A -18.02%

Prenetics Global presently has a consensus target price of $34.25, suggesting a potential upside of 83.01%. Owlet has a consensus target price of $15.00, suggesting a potential upside of 184.63%. Given Owlet's higher possible upside, analysts plainly believe Owlet is more favorable than Prenetics Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Owlet beats Prenetics Global on 11 of the 16 factors compared between the two stocks.

How does Owlet compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

In the previous week, Standard BioTools had 1 more articles in the media than Owlet. MarketBeat recorded 3 mentions for Standard BioTools and 2 mentions for Owlet. Owlet's average media sentiment score of 1.34 beat Standard BioTools' score of 0.62 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Standard BioTools
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Owlet has higher revenue and earnings than Standard BioTools. Owlet is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Standard BioTools$85.33M4.14-$74.90M$0.204.52
Owlet$107.06M1.43-$39.68M-$3.07N/A

Standard BioTools presently has a consensus price target of $1.35, indicating a potential upside of 49.34%. Owlet has a consensus price target of $15.00, indicating a potential upside of 184.63%. Given Owlet's stronger consensus rating and higher possible upside, analysts plainly believe Owlet is more favorable than Standard BioTools.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Standard BioTools
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 26.8% of Standard BioTools shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Standard BioTools has a net margin of 73.46% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Standard BioTools' return on equity.

Company Net Margins Return on Equity Return on Assets
Standard BioTools73.46% -8.18% -6.43%
Owlet -42.54%N/A -18.02%

Standard BioTools has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, Owlet has a beta of 1.84, suggesting that its share price is 84% more volatile than the broader market.

Summary

Owlet beats Standard BioTools on 10 of the 16 factors compared between the two stocks.

How does Owlet compare to Syntec Optics?

Owlet (NYSE:OWLT) and Syntec Optics (NASDAQ:OPTX) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Owlet has a beta of 1.84, suggesting that its share price is 84% more volatile than the broader market. Comparatively, Syntec Optics has a beta of -0.86, suggesting that its share price is 186% less volatile than the broader market.

Syntec Optics has a net margin of -10.95% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Syntec Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Syntec Optics -10.95%-30.86%-12.35%

Syntec Optics has lower revenue, but higher earnings than Owlet. Syntec Optics is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$107.06M1.43-$39.68M-$3.07N/A
Syntec Optics$27.53M9.97-$1.79M-$0.08N/A

In the previous week, Syntec Optics had 2 more articles in the media than Owlet. MarketBeat recorded 4 mentions for Syntec Optics and 2 mentions for Owlet. Owlet's average media sentiment score of 1.34 beat Syntec Optics' score of 0.64 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Syntec Optics
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Owlet currently has a consensus price target of $15.00, suggesting a potential upside of 184.63%. Given Owlet's stronger consensus rating and higher possible upside, research analysts plainly believe Owlet is more favorable than Syntec Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Syntec Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

72.6% of Owlet shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 0.8% of Syntec Optics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Owlet beats Syntec Optics on 10 of the 16 factors compared between the two stocks.

How does Owlet compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Owlet (NYSE:OWLT) are related small-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

In the previous week, 908 Devices had 4 more articles in the media than Owlet. MarketBeat recorded 6 mentions for 908 Devices and 2 mentions for Owlet. Owlet's average media sentiment score of 1.34 beat 908 Devices' score of 0.73 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
908 Devices
0 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

908 Devices has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, Owlet has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market.

88.1% of 908 Devices shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 28.2% of 908 Devices shares are owned by insiders. Comparatively, 36.2% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

908 Devices currently has a consensus price target of $11.50, indicating a potential upside of 41.02%. Owlet has a consensus price target of $15.00, indicating a potential upside of 184.63%. Given Owlet's stronger consensus rating and higher probable upside, analysts clearly believe Owlet is more favorable than 908 Devices.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

908 Devices has higher earnings, but lower revenue than Owlet. 908 Devices is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
908 Devices$57.80M5.34$19.49M-$1.00N/A
Owlet$107.06M1.43-$39.68M-$3.07N/A

Owlet has a net margin of -42.54% compared to 908 Devices' net margin of -62.40%. Owlet's return on equity of 0.00% beat 908 Devices' return on equity.

Company Net Margins Return on Equity Return on Assets
908 Devices-62.40% -14.03% -10.40%
Owlet -42.54%N/A -18.02%

Summary

Owlet beats 908 Devices on 10 of the 16 factors compared between the two stocks.

Get Owlet News Delivered to You Automatically

Sign up to receive the latest news and ratings for OWLT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OWLT vs. The Competition

MetricOwletHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$153.11M$5.72B$6.81B$23.73B
Dividend YieldN/A1.79%2.59%4.21%
P/E Ratio-1.7223.62282.1231.30
Price / Sales1.4357.68573.08165.84
Price / CashN/A32.5328.6018.73
Price / Book7.426.4311.024.81
Net Income-$39.68M$151.15M$3.49B$1.07B
7 Day Performance0.76%2.70%0.47%0.60%
1 Month Performance-8.97%-1.83%-4.24%0.38%
1 Year Performance-28.69%4.26%62.63%20.06%

Owlet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OWLT
Owlet
2.5129 of 5 stars
$5.27
+2.5%
$15.00
+184.6%
-30.3%$153.11M$107.06MN/A106
CTKB
Cytek Biosciences
2.2165 of 5 stars
$4.46
+1.1%
$5.69
+27.5%
+15.9%$569.52M$201.49MN/A500
PRE
Prenetics Global
1.6024 of 5 stars
$18.26
-3.5%
$34.25
+87.6%
+133.0%$319.43M$92.39MN/A1
LAB
Standard BioTools
3.5891 of 5 stars
$0.79
+2.6%
$1.35
+69.9%
-33.2%$302.38M$85.33M3.97620
OPTX
Syntec Optics
0.218 of 5 stars
$6.38
-10.6%
N/A+281.9%$287.60M$28.08MN/A3

Related Companies and Tools


This page (NYSE:OWLT) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners